Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
FEBANTEL, PYRANTEL EMBONATE, PRAZIQUANTEL
Divasa-Farmavic S.A.
QP52AA30
FEBANTEL, PYRANTEL EMBONATE, PRAZIQUANTEL
150/144/50 Milligram
Tablets
CAM-Companion Animal Medicine
Canine
Combinations of quinoline derivatives and related substances
Endoparasiticide
Authorised
2013-12-13
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Wellplus Flavoured tablets for Dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Praziquantel 50 mg Pyrantel embonate 144 mg Febantel 150 mg EXCIPIENTS: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets. Yellowish round tablets with brown dots. The tablets can be divided into equal halves or equal quarters. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed infestations with the following roundworms and tapeworms in dogs and puppies: Ascarids: _Toxocara canis_, _Toxascaris leonina _(adult and late immature forms) Hookworms: _Uncinaria stenocephala_, _Ancylostoma caninum _(adults) Tapeworms: _Echinococcus granulosus_, _Echinococcus multilocularis_, _Dipylidium caninum_, _Taenia _spp., _Multiceps_ _multiceps _(adult and immature forms) 4.3 CONTRAINDICATIONS Do not use simultaneously with piperazine compounds. Do not use in cases of known hypersensitivity to the active substances or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Fleas serve as intermediate hosts for one common type of tapeworm – _Dipylidium caninum_. Tapeworm infestation is certain to reoccur unless control of intermediate hosts such as fleas, mice, etc. is undertaken. Tapeworm infestation is unlikely in pups less than 6 weeks of age. Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 14/12/2013_ _CRN 7013606_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN A Lire le document complet